Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm

被引：0
|
作者：
Zibelman, Matthew [1 ]
Plimack, Elizabeth R. [1 ]
机构：
[1] Temple Hlth, Fox Chase Canc Ctr, Philadelphia, PA USA
来源：
ONCOLOGY-NEW YORK | 2016年 / 30卷 / 02期
关键词：
BACILLUS-CALMETTE-GUERIN; BLADDER-CANCER; CTLA-4; BLOCKADE; MITOMYCIN-C; METAANALYSIS; TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：160 / +
页数：4
相关论文
共 50 条
  • [41] Subsequent Systemic Therapy following Platinum and Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
    Hong, Joohyun
    Sung, Hyun Hwan
    Jeong, Byong Chang
    Park, Se Hoon
    [J]. BIOMEDICINES, 2022, 10 (08)
  • [42] Adjuvant immune checkpoint inhibitors for urothelial carcinoma: systematic review and Meta-analysis
    Sayyid, Rashid K.
    Bernardino, Rui
    Chavarriaga, Julian
    Kumar, Ravi
    Randhawa, Harkanwal
    Wettstein, Marian S.
    Cockburn, Jessica Grace
    Klaassen, Zachary
    Fleshner, Neil E.
    [J]. WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [43] Combination therapies involving checkpoint-inhibitors for treatment of urothelial carcinoma: a narrative review
    Schulz, Gerald B.
    Black, Peter C.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (10) : 4014 - 4021
  • [44] #Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?
    Dhariwal, Randeep
    Pindoria, Nisha
    Dasgupta, Prokar
    Khan, Muhammad S.
    [J]. BJU INTERNATIONAL, 2019, 123 (02) : 203 - 207
  • [45] Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Makrakis, Dimitrios
    Talukder, Rafee
    Lin, Genevieve Ihsiu
    Diamantopoulos, Leonidas N.
    Dawsey, Scott
    Gupta, Shilpa
    Carril-Ajuria, Lucia
    Castellano, Daniel
    de Kouchkovsky, Ivan
    Koshkin, Vadim S.
    Park, Joseph J.
    Alva, Ajjai
    Bilen, Mehmet A.
    Stewart, Tyler F.
    Mckay, Rana R.
    Tripathi, Nishita
    Agarwal, Neeraj
    Vather-Wu, Naomi
    Zakharia, Yousef
    Morales-Barrera, Rafael
    Devitt, Michael E.
    Cortellini, Alessio
    Fulgenzi, Claudia Angela Maria
    Pinato, David J.
    Nelson, Ariel
    Hoimes, Christopher J.
    Gupta, Kavita
    Gartrell, Benjamin A.
    Sankin, Alex
    Tripathi, Abhishek
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Murgic, Jure
    Frobe, Ana
    Rodriguez-Vida, Alejo
    Drakaki, Alexandra
    Liu, Sandy
    Lu, Eric
    Kumar, Vivek
    Di Lorenzo, Giuseppe
    Joshi, Monika
    Isaacsson-Velho, Pedro
    Buznego, Lucia Alonso
    Duran, Ignacio
    Moses, Marcus
    Jang, Albert
    Barata, Pedro
    Sonpavde, Guru
    Yu, Evan Y.
    Montgomery, Robert Bruce
    [J]. CLINICAL GENITOURINARY CANCER, 2022, 20 (05) : E440 - E452
  • [46] Combination Therapy With Immune Checkpoint Inhibitors in Urothelial Carcinoma: Current Data and Future Outlook
    Feng, Zizhen
    Vuky, Jacqueline
    [J]. ONCOLOGY-NEW YORK, 2021, 35 (07): : 410 - 420
  • [47] Immune Checkpoint Inhibitors Effective in Urothelial Cancer
    Brower, Vicki
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (05)
  • [48] ANTICANCER DRUGS Translational target for checkpoint inhibitors
    Kingwell, Katie
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (12) : 863 - 863
  • [49] Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with advanced urothelial carcinoma
    Beom, Seung-Hoon
    Rha, Sun Young
    Ahn, Joong Bae
    Shin, Sang Joon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [50] Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial Carcinoma COMMENT
    Soleimani, Maryam
    Eigl, Bernhard J.
    [J]. JOURNAL OF UROLOGY, 2021, 205 (03): : 717 - 717
12345